Pressroom: Media Coverage

Showing 401 - 420 of 555 news items


Mammogram Rates Lower for Mexican Women in US

Epidemiologist Elena Elkin discussed a study that found that Mexican women in the US are less likely to get mammograms than white women, black women and other Latinas.

December 20, 2011
The Race Is On for a Better Mammogram

Breast imaging radiologist Elizabeth Morris commented on the limitations of mammography in this article about nuclear physicist Dr. Edward Flynn, who was inspired by his wife’s cancer to create a better procedure.

December 19, 2011
A Harvard Doctor's Startup Trains Hospitals to Rehab Cancer Survivors

Dr. Julie Silver, a breast cancer survivor, co-founded a company to help hospitals and rehab centers tailor rehab programs to cancer patients. Memorial Sloan Kettering’s Michael Stubblefield discussed Memorial Sloan Kettering’s Rehabilitation Service, which has grown from two therapists to 18 as its focus has broadened to address the comprehensive rehab needs of cancer patients.

December 16, 2011
Tex Visits with Kids

Mark Teixeira of the New York Yankees paid a special holiday visit to the Department of Pediatrics. Memorial Sloan Kettering’s Richard O’Reilly was interviewed.

December 15, 2011
When Care Is Worth It, Even if End Is Death - New York Times Essay

Memorial Sloan Kettering epidemiologist Peter Bach wrote an essay about the amount of money spent on providing care to patients who may die.

December 13, 2011
Early Hodgkin Lymphoma Patients Can Skip Radiation Therapy, Study Finds

Memorial Sloan Kettering’s David Straus discussed an editorial he wrote in response to a study that found that patients with early stages of Hodgkin lymphoma would benefit from chemotherapy alone because adding radiation leads to higher death rates.

December 11, 2011
Two Drugs Appear to Delay Progression of Breast Cancer

Memorial Sloan Kettering’s Clifford Hudis commented on studies presented at the San Antonio Breast Cancer Symposium that showed that two new combinations of drugs significantly slowed the progression of tumors among women fighting metastatic breast cancer. Larry Norton also commented on the studies in The Washington Post.

December 8, 2011
Prostate Cancer Hormonal Therapy Cuts Deaths

Memorial Sloan Kettering researcher Behfar Ehdaie discussed findings that showed that hormone-targeted therapy cuts the overall risk of death for men with aggressive prostate cancer.

December 6, 2011
Staying the Course

Memorial-Sloan Kettering’s Andrew Zelenetz discussed maintenance therapy. Typically, cancer treatments are administered for a limited time to stabilize a cancer and its symptoms or to put it into remission, and treatment resumes only if the cancer gets worse or comes back. Maintenance therapy fights off any cancer cells that might remain in the body after the initial therapy.

December 5, 2011
Boosting Defenses Against Cancer

Immunologist James Allison answered questions about the immunotherapy drug he developed, called ipilimumab (Yervoy™), approved by the FDA in March for patients with metastatic melanoma.

December 5, 2011
Lloyd J. Old, Champion of Using Cells to Fight Cancer, Dies at 78

Memorial Sloan Kettering’s Lloyd Old, internationally recognized as one of the founders and standard bearers of the field of tumor immunology, died on November 28. Immunologist and colleague James Allison commented on his passing in The Scientist.

December 5, 2011
Dogs with Cancer Helping to Find a Cure

Medical oncologist Jedd Wolchok talked about a drug he co-developed based on a therapeutic vaccine for dogs with melanoma.

December 2, 2011
Hormonal Prostate Cancer Therapy Tied to Blood Clots

Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, according to a new study published by Memorial Sloan Kettering researcher Behfar Ehdaie in the journal Cancer.

December 1, 2011
The Healthy Man

Chief of Memorial Sloan Kettering’s Rockville Centre’s Medical Oncology Service Kenneth Ng discussed what doctors want men to know about lung cancer.

December 1, 2011
Unexpected Complications: Treating Cancer during Pregnancy

Chief of Memorial Sloan Kettering’s Breast Cancer Medicine Service Clifford Hudis was quoted about the rarity of cancer in pregnancy and the difficulties associated with doing meaningful research in patients with cancer who are pregnant.

November 29, 2011
New Therapy Targets a Patient's Unique Cancer

Thoracic oncologist Mark Kris discussed molecular tumor typing and personalized medicine in the treatment of lung and other cancers.

November 23, 2011
Drug-Resistant Melanoma Finding May Improve Treatment Approach

Cancer researcher and member of the Human Oncology and Pathogenesis Program David Solit discussed a paper he published in Nature that identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib. Dr. Solit was also quoted in the NCI Cancer Bulletin.

November 23, 2011
Should Medical School Be Free?

Epidemiologist Peter Bach talked about how making medical school free could send more young doctors into primary care and rural practice, thus solving one of the big challenges facing healthcare today.

November 21, 2011
Hospitals Increasingly Offer Complementary Medicine Treatments

Integrative Medicine Chief Barrie Cassileth responded to a survey finding that 42 percent of US hospitals offer at least one type of complementary medicine treatment. She warned that many herbal remedies create herb/drug interactions and emphasized the importance of offering evidence-based information about such interactions on Memorial Sloan Kettering’s About Herbs, Botanicals & Other Products database.

November 15, 2011
Helping Cancer Survivors Achieve a Healthy Weight

Director of the Adult Long-Term Follow-Up Program Kevin Oeffinger discussed why some cancer survivors are more likely than others to be overweight or obese.

November 15, 2011